Peptidome profiling of ovarian cancer and non-cancer proximal fluids: ascites and blood sera
Ontology highlight
ABSTRACT: Ovarian cancer is the most lethal gynecological malignancy, because its early detection is difficult due to the absence of recognizable physical symptoms and a lack of sensitive screening methods. Despite a large number of proteomic studies of biological fluids from ovarian cancer patients, only a few biomarkers are used in clinical practice. Low molecular weight endogenous peptides more easily diffuse across endothelial barriers and can be more relevant biomarker candidates. In this current study, detailed peptidomic analysis of 26 ovarian cancer and 15 non-cancer samples of biological fluids (ascites and sera) were performed using TripleTOF 5600+ mass-spectrometer.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Blood Serum, Ascites
DISEASE(S): Cirrhosis,Disease Free,Malignant Neoplasm Of Ovary
SUBMITTER:
Georgij Arapidi
LAB HEAD: Georgij Arapidi
PROVIDER: PXD009382 | Pride | 2018-04-05
REPOSITORIES: Pride
ACCESS DATA